These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20048439)

  • 1. [Calcium antagonists: current and future applications based on new evidence. Cardio-protective effect of calcium antagonists].
    Hongo K; Yoshimura M
    Clin Calcium; 2010 Jan; 20(1):89-93. PubMed ID: 20048439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium antagonists: current and future applications based on new evidence. Neuroprotective effect of calcium antagonists].
    Ito Y; Araki N
    Clin Calcium; 2010 Jan; 20(1):83-8. PubMed ID: 20048438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
    Gattis W; O'Connor CM
    Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium antagonists and treatment of chronic heart failure].
    Lanfranchi J
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):623-31. PubMed ID: 7487313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined heart protection for the hypertensive patient].
    MMW Fortschr Med; 2013 Jan; 155(1):66-7. PubMed ID: 23573728
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium channels in the heart.
    Poole-Wilson PA
    Postgrad Med J; 1991; 67 Suppl 3():S16-9. PubMed ID: 1661893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridines and vascular diseases.
    Tamargo J; Delpón E
    Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertrophic effect of dihydropyridines calcium channel blockers is dependent on their potential of blocking N-type calcium channel].
    Luo Q; Xuan WL; Xi F; Liao YL; Kitakaze M
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):755-9. PubMed ID: 20423843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists and ischemic heart disease].
    Simon K; Vályi P; Szépvölgyi A; Badics A; Böhm T
    Orv Hetil; 1996 Sep; 137(39):2131-6. PubMed ID: 8927361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and EBM].
    Toba A; Kuwajima I
    Clin Calcium; 2010 Jan; 20(1):9-15. PubMed ID: 20048428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium channel inhibitors and ventricular filling].
    Dorobantu M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1579-85. PubMed ID: 1300955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].
    Richard S; Virsolvy A; Fort A
    Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):166-73. PubMed ID: 18565491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.